TRANSCRIPTION ACTIVATION BY HIV, TAT, HTLV TAX & HBV PX
TRANSCRIPTION ACTIVATION BY HIV, TAT, HTLV TAX & HBV PX
批准号:
6215448
负责人:
MICHAEL R GREEN
金额:
$26.96万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-09-01 至 2005-08-31
中文摘要
描述(来自研究者摘要):这是一个竞争性更新
英文摘要
DESCRIPTION (from investigator's abstract): This is a competitive renewal
application. The previous grant was for studying how the trancriptional
regulatory proteins of three pathogenic viruses activate transcription,
specifically, the Tat protein of human immunodeficiency virus type 1 (HIV-1),
the Tax protein of human T-cell leukemia virus type 1 (HTLV-1), and the pX
protein of hepatitis B virus (HBV). In this application, the applicant seeks to
understand in greater detail the mechanism of action of these viral regulatory
proteins and their role in viral replication and human disease. The rationale
for the proposal relies heavily on two relatively new technologies. First, the
chromatin immunoprecipitation (ChIP) assay, which allows for the detection of
specific proteins that are physically associated with DNA in living cells.
Second, the genome-wide expression analysis using high density DNA microarrays,
which enables the analysis of transcription profiles of a large array of human
genes. The specific aims are: (1) To understand in greater detail how HIV-1 Tat
stimulates transcription in vitro and in vivo. The investigator has identified
a Tat cofactor, Tat-SF1, and has shown that it is a general transcription
elongation factor. A second elongation factor has been implicated, AIEF, and
remains to be identified. Tat-SF1 and AIEF and the mechanisms of Tat activation
in vivo will be investigated further. (2) To study how HTLV-1 Tax and HBV pX
regulates DNA binding of cellular bZIP proteins. The investigator has shown
that Tax and pX dramatically increase the DNA binding activity and alter the
target selectivity of a wide variety of cellular proteins that possess a basic
region-leucine zipper (bZIP) DNA binding domain, through promotion of
dimerization. Experiments are proposed to undersstand the basis of altered DNA
binding specificity, the cellular proteins involved, and details of the
DNA-protein interactions. (3) To analyze how HTLV-1 Tax and HBV pX activate
transcription in vivo and transform cells. To test the prediction of different
models of how these proteins activate transcription, to identify cellular
proteins involved in the activation, and to identify cellular genes activated
that may contribute to disease.
(4) To understand the mechanism of BEF action. The investigator has identified
a nuclear protein BEF (for bZIP-enhancing factor) which is required for bZIP
prtoein functions, work synergistically with Tax and pX. However, BEF works by
a different mechanism, as a molecular chaperone. Experiments are proposed to
further study the mechanism of BEF action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transcriptional Upregulation of the Epigenetically Repressed FXN Gene as a Therapeutic Approach for Friedreich Ataxia
-
批准号:10020200
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2019
-
负责人:MICHAEL R GREEN
-
依托单位:
Transcriptional Upregulation of the Epigenetically Repressed FXN Gene as a Therapeutic Approach for Friedreich Ataxia
-
批准号:10171630
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2019
-
负责人:MICHAEL R GREEN
-
依托单位:
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
-
批准号:9901470
-
项目类别:
-
资助金额:$59.05万
-
财政年份:2018
-
负责人:MICHAEL R GREEN
-
依托单位:
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
-
批准号:10133462
-
项目类别:
-
资助金额:$58.51万
-
财政年份:2018
-
负责人:MICHAEL R GREEN
-
依托单位:
Reactivation of Epigenetically Silenced FMR1 as a Therapeutic Approach for Fragile X Syndrome
-
批准号:10217959
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2017
-
负责人:MICHAEL R GREEN
-
依托单位:
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
-
批准号:8733134
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2013
-
负责人:MICHAEL R GREEN
-
依托单位:
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
-
批准号:8578767
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2013
-
负责人:MICHAEL R GREEN
-
依托单位:
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
-
批准号:9293268
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2013
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7572913
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7221162
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7355590
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7766916
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7094964
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
CONFERENCE--TRANSCRIPTION REGULATION
-
批准号:3434748
-
项目类别:
-
资助金额:$0.2万
-
财政年份:1992
-
负责人:MICHAEL R GREEN
-
依托单位:
HIV-1 REV PROTEIN--BIOCHEMICAL MECHANISMS
-
批准号:6169685
-
项目类别:
-
资助金额:$27.76万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
Intracellular Localization of HIV-1 RNAs by Rev&Matrix
-
批准号:6631919
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
HIV-1 REV PROTEIN--BIOCHEMICAL MECHANISMS
-
批准号:2672095
-
项目类别:
-
资助金额:$25.7万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
HIV-1 REV PROTEIN--BIOCHEMICAL MECHANISMS
-
批准号:2886725
-
项目类别:
-
资助金额:$26.71万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
Intracellular Localization of HIV-1 RNAs by Rev&Matrix
-
批准号:6876153
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
HIV-1 REV PROTEIN--BIOCHEMICAL MECHANISMS
-
批准号:2066863
-
项目类别:
-
资助金额:$24.03万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
海外基金